With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback